Literature DB >> 19218640

Superoxide dismutase mimetic modulates hyperoxic augmentation of the diaphragmatic response to poikilocapnic hypoxia in non-vagotomized rats.

K Budzinska1, R Ilasz.   

Abstract

A period of oxygen breathing enhances the subsequent respiratory responses to episodic hypoxia. Since hyperoxia increases a formation of reactive oxygen species (ROS) in lungs, in the present study we asked a question of whether superoxide anion produced during O(2) breathing would participate in the mechanisms of posthyperoxic enhancement of the response to hypoxia and whether afferent information from the lungs would contribute to this response. To scavenge a superoxide we used Tempol (4-hydroxy-2,2,6,6-tetra-methyl piperidine-N-oxyl), a superoxide dismutase mimetic. The respiratory activity of anesthetized, spontaneously breathing rats was assessed from the integrated costal diaphragm EMG. The experiments consisted of 3 min hypoxia (11% O(2)), before and after a 15 min period of breathing with 100% oxygen, with and without Tempol (33 mg/kg) preatreatment. The same protocol was performed in non-vagotomized and vagotomized rats. The results show that a SOD mimetic abolished both hyperoxia-induced slowing of respiration and posthyperoxic respiratory augmentation of the hypoxic response. The abolishment is due likely to a remodeling of the respiratory pattern involving lung vagal reeptors, since in vagotomized animals, the effects of Tempol were marginal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218640

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  2 in total

1.  Short-term oxygen administration restores blunted baroreflex sensitivity in patients with type 1 diabetes.

Authors:  L Bernardi; M Rosengård-Bärlund; A Sandelin; V P Mäkinen; C Forsblom; P-H Groop
Journal:  Diabetologia       Date:  2011-06-07       Impact factor: 10.122

2.  Parasympathetic Stimuli on Bronchial and Cardiovascular Systems in Humans.

Authors:  Emanuela Zannin; Riccardo Pellegrino; Alessandro Di Toro; Andrea Antonelli; Raffaele L Dellacà; Luciano Bernardi
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.